Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory T Wolf

Showing results (211-220 of 217) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 217 results.
Nature Communications|December 28, 2025
BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunityWang Gong, Hülya F Taner, Yuesong Wu, et al.
Head & Neck|September 26, 2017
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinomaHongzheng Zhang, Sungjin Kim, Zhengjia Chen, et al.
Carcinogenesis|June 25, 2015
The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisJosiah Ochieng, Gladys N Nangami, Olugbemiga Ogunkua, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Head and Neck Cancers, Version 1.2015David G Pfister, Sharon Spencer, David M Brizel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2013
Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelinesDavid G Pfister, Kie-Kian Ang, David M Brizel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 15, 2014
Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncologyDavid G Pfister, Sharon Spencer, David M Brizel, et al.
Carcinogenesis|June 25, 2015
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadWilliam H Goodson, Leroy Lowe, David O Carpenter, et al.
Pageof 22

Showing results (211-220 of 217) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 217 results.
Nature Communications|December 28, 2025
BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunityWang Gong, Hülya F Taner, Yuesong Wu, et al.
Head & Neck|September 26, 2017
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinomaHongzheng Zhang, Sungjin Kim, Zhengjia Chen, et al.
Carcinogenesis|June 25, 2015
The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisJosiah Ochieng, Gladys N Nangami, Olugbemiga Ogunkua, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Head and Neck Cancers, Version 1.2015David G Pfister, Sharon Spencer, David M Brizel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2013
Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelinesDavid G Pfister, Kie-Kian Ang, David M Brizel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 15, 2014
Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncologyDavid G Pfister, Sharon Spencer, David M Brizel, et al.
Carcinogenesis|June 25, 2015
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadWilliam H Goodson, Leroy Lowe, David O Carpenter, et al.
Pageof 22